Aquapharm Biodiscovery
Newyork, Argyll and Bute, United Kingdom
About Aquapharm Biodiscovery
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $16.2M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2010)
- Website: aquapharm.co.uk
- Phone: 44-(0)-1631-559-393
Industries & Categories
Biotechnology, Chemical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aquapharm-biodiscovery-2492496 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.